N-.omega.-Fluoroalkyl Analogs of (1R)-2.beta.-Carbomethoxy-3.beta.-(4-iodophenyl)tropane (.beta.-CIT): Radiotracers for Positron Emission Tomography and Single Photon Emission Computed Tomography Imaging of Dopamine Transporters (original) (raw)

Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease

Gerda Andringa

NeuroImage, 2005

View PDFchevron_right

Dopamine transporter imaging with fluorine-18-FPCIT and PET

Vijay Dhawan

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998

View PDFchevron_right

18F-FECNT: Validation as PET dopamine transporter ligand in parkinsonism

Leonard Howell

Experimental Neurology, 2010

View PDFchevron_right

SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys

Bertha Madras

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997

View PDFchevron_right

Synthesis, Biodistribution, and Primate Imaging of Fluorine-18 Labeled 2β-Carbo-1‘-fluoro-2-propoxy-3β-(4-chlorophenyl)tropanes. Ligands for the Imaging of Dopamine Transporters by Positron Emission Tomography

Vernon Camp

Journal of Medicinal Chemistry, 2000

View PDFchevron_right

In Vivo Dopamine Transporter Imaging in a Unilateral 6-Hydroxydopamine Rat Model of Parkinson Disease Using 11C-Methylphenidate PET

Salma Jivan

Journal of Nuclear Medicine, 2012

View PDFchevron_right

Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans

Nathaniel Alpert, Bradley Christian

Nuclear Medicine and Biology, 2014

View PDFchevron_right

Parkinson’s disease and dopamine transporter neuroimaging: a critical review

Rodrigo Bressan, Luiz Augusto Franco Andrade

Sao Paulo Medical Journal, 2006

View PDFchevron_right

123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson?s disease, multiple system atrophy, and progressive supranuclear palsy

Margherita Canesi

Neurological Sciences, 2003

View PDFchevron_right

Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling

Marie-Anne Peyronneau

Nuclear Medicine and Biology, 2012

View PDFchevron_right

Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism

Tadashi Nozaki

Nuclear Medicine and Biology, 1996

View PDFchevron_right

Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects

S-O Yang

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997

View PDFchevron_right

Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET

Vijay Dhawan

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996

View PDFchevron_right

Synthesis and radiopharmacological characterization of 2β-carbo-2′-[18F]fluoroethoxy-3β-(4-bromo-phenyl)tropane ([18F]MCL-322) as a PET radiotracer for imaging the dopamine transporter (DAT)

Jens Pietzsch

Bioorganic & Medicinal Chemistry, 2007

View PDFchevron_right

Dopaminergic Function and Dopamine Transporter Binding Assessed With Positron Emission Tomography in Parkinson Disease

Philippe Hantraye

Archives of Neurology, 2002

View PDFchevron_right

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders

Ayşe Bora Tokçaer

Turkish Journal of Medical Sciences, 2021

View PDFchevron_right

Reproducibility and Discriminating Ability of Fluorine-18-6-Fluoro-L-Dopa PET in Parkinson's Disease

Thomas Ruth

The Journal of Nuclear Medicine, 1996

View PDFchevron_right

Technepine: A high-affinity99mtechnetium probe to label the dopamine transporter in brain by SPECT imaging

Alun Jones

Synapse, 1996

View PDFchevron_right

Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients

Wen-sheng Huang

Journal of Nuclear Medicine, 2003

View PDFchevron_right

Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys

Hideo Tsukada

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016

View PDFchevron_right

18F]Fluoro-l-dopa for the in vivo study of intracerebral dopamine

Gunter Firnau

International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986

View PDFchevron_right